Abstract
HLA-A and-B are expressed by most cell types, and their levels can be increased by treatment with interferons (IFNs). The relative basal levels of HLA-A and-B expression can vary, and HLA-B loci are induced much more strongly by IFNs. Constitutive activity is dependent on an upstream enhancer (ENH) which contains a rel (KBF, NFκB) binding motif, and induction is mediated by an interferon response element (IRE) which binds members of the IRF family. Reported here is the identification of a regulatory element, ‘R’, which overlaps the IRE of HLA-B loci, but which is absent from the equivalent region of HLA-A or H2 class I genes. The core of the element, CACGAG, is bound by a nuclear factor which is recognized by an antiserum raised against the upstream stimulation factor (USF), a member of the helix-loop-helix/leucine zipper family. The use of reporter gene constructs shows that mutation of the R element results in increased induction by IFNα in some cell lines, which appears to be due to competitive binding of USF with IRF proteins.
Similar content being viewed by others
References
Baldwin, Jr, A. S., LeClair, K. P., Singh, H., and Sharp, P. A. A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes. Mol Cell Biol 10: 1406–1414, 1990
Beckman, H., Su, L.-K, and Kadesch, T. TFE3: A helix-loop-helix protein that activates transcription through the immunoglobulin enhancer μE3 motif. Genes Dev 4: 167–179, 1990
Benezra, R., Davis, R. L., Lockshon, D., Turne, D. L., and Wientraub, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61: 49–59, 1990
Bengal, E., Ransone, L., Scharfmann, R., Dwarki, V. J., Tapscott, S. J., Weintraub, H., and Verma, I. M. Functional antagonism between c-Jun and MyoD proteins: a direct physical interaction. Cell 68: 507–519, 1992
Bernards, R., Dessain, S. K., and Weinberg, R. A. N-myc amplification causes down-regulation of MHC class I antigen expression in neuroblastoma. Cell 47: 667–674, 1986
Blanchet, O., Bourge, J.-F., Zinszner, H., Israel, A., Kourilsky, P., Dausset, J., Degos, L., and Paul, P. Altered binding of regulatory factors to HLA class I enhancer sequence inhuman tumor cell lines lacking class I antigen expression. Proc Nat Acad Sci USA 89: 3488–3492, 1992
Briggs, M. R., Kadonaga, J. T., Bell, S. P., and Tjian, R. Purification and biochemical characterization of the promoter-specific transcription factor, SP1. Science 234: 47–52, 1986
Burrone, O. R., Kefford, R. F., Gilmore, D., and Milstein, C. Stimulation of HLA-A, B, C by IFN-alpha. The derivation of Molt4 variants and the differential expression of HLA-A, B, C subsets. EMBO J 4: 2855–2860, 1985
Burrone, O. R. and Milstein, C. Control of HLA-A, B, C synthesis and expression in Interferon-treated cells. EMBO J 1: 345–349, 1982
Carthew, R. W., Chodosh, L. A., and Sharp, P. A. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell 43: 439–448, 1985
David-Watine, B., Israel, A., and Kourilsky, P. The regulation and expression of MHC class I genes. Immunol Today 11: 286–292, 1990
Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475–1489, 1983
Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W.-H., Marks, M. S., B-Z., L., Flanagan, J. R., Apella, E., and Ozato, K. An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Nat Acad Sci USA 87: 3743–3747, 1990
Eager, K. B., Pfizenmaier, K., and Ricciardi, R. P. Modulation of major histocompatibility complex (MHC) class I genes in adenovirus 12 transformed cells: Interferon-γ increases class I expression by a mechanism that circumvents E1A induced-repression and tumor necrosis factor enhances the effect of interferon-γ. Oncogene 4: 39–44, 1989
Eager, K. B., Williams, J., Breiding, D., Pan, S., Knowles, B., Appella, E., and Ricciardi, R. P. Expression of histocompatibility antigens H-2K,-D, and-L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon γ. Proc Nat Acad Sci USA 82: 5525–5529, 1985
Ephrussi, A., Church, G. M., Tonegawa, S., and Gilbert, W. B. Lineage specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227: 134–140, 1985
Fisher, D. E., Parent, L. A., and Sharp, P. A. Myc/Max and other helix-loop-helix/leucine zipper proteins bend DNA toward the minor groove. Proc Nat Acad Sci USA 89: 11779–11783, 1992
Fisher, F. and Goding,C. R. Single amino acid substitutions alter helix-loop-helix protein specificity from bases flanking the core CANNTG motif. EMBO J 11: 4103–4109, 1992
Flanagan, J. R., Murata, M., Burke, P. A., Shirayoshi, Y., Appella, E., Sharp, P. A., and Ozato, K. Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells. Proc Nat Acad Sci USA 88: 3145–3149, 1991
Friedman, R. L., and Stark, G. R. Alpha interferon induces transcription of HLA and metallothionein genes which have homologous upstream sequences. Nature 314: 637–639, 1985
Giacca, M., Gutierrez, M. I., Menzo, S., di Fagagna, F. D., and Falaschi, A. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. Virology 186: 133–147, 1992
Girdlestone, J. Nucleotide sequence of an HLA-A1 gene. Nucleic Acids Res 18: 6701, 1990
Girdlestone, J. and Milstein, C. Differential expression and interferon response of HLA class I genes in thymocyte lines and response variants. Eur J Immunol 18: 139–143, 1988
Gussow, D., Rein, R. S., Meijer, I., de Hoog, W., Seemann, G. H. A., Hochstenbach, F.M., Ploegh, H. L Isolation expression and primary structure of HLA-Cw1 and-Cw2 genes: evolutionary aspects. Immunogenetics 25: 313–322, 1987
Hakem, R., le Bouteiller, P., Jezo-Bremond, A., Harper, K., Campese, D., and Lemonnier, F. A. Differential regulation of HLA-A3 and HLA-B7 class I genes by IFN is due to two nucleotide differences in their IFN response sequences. J Immunol 147: 2384–2390, 1991
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., and Taniguchi, T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729–739, 1989
Henseling, U., Schmidt, W., Scholer, H. R., Gruss, P., and Hatzopoulos, A. K. A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes. Mol Cell Biol 10: 4100–4109, 1990
Isamat, M., Girdlestone, J., and Milstein, C. Nucleotide sequence of an HLA-Bw57 gene. Nucleic Acids Res 18: 6702, 1990
Israël, A., Kimura, A., Fournier, A., Fellous, M., and Kourilsky, P. Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature 322: 743–746, 1986
Israel, A., Le Bail, O., Hatat, D., Piette, J., Kieran, M., Logeat, F., Wallach, D., Fellous, M., and Kourilsky, P. TNF stimulates expression of mouse MHC class I genes by inducing an NFκB-like enhancer binding activity which displaces constitutive factors. EMBO J 8: 3793–3800, 1989
Jiang, J. and Levine, M. Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen. Cell 72: 741–752, 1993
Johnson, D. R. and Pober, J. S. Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy-and light-chain genes in vascular endothelium. Proc Nat Acad Sci USA 87: 5183–5187, 1990
Kadesch, T. Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription. Immunol Today 13: 31–36, 1992
Kaklamanis, L., Gatter, K. C., Hill, A. B., Mortenson, N., Harris, A. L., Krausa, P., McMichael, A., Bodmer, J. G., and Bodmer, W. F. Loss of HLA class I alleles, heavy chains and β2-microglobulin in colorectal cancer. Int J Cancer 51: 379–385, 1992
Kieran, M., Blank, V., Logeat, F., Vandekerckhove, J., Lottspeich, F., Le Bail, O., Urban, M. B., Kourilsky, P., Baeuerle, P. A., and Israël, A. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62: 1007–1018, 1990
Kimura, A., Israël, A., Le Bail, O., and Kourilsky, P. Detailed analysis of the mouse H-2K b promoter: enhancer-like sequences and their role in the regulation of class I gene expression. Cell 41: 261–272, 1986
Kingsley, C. and Winoto, A. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Biol 12: 4251–4261, 1992
Koller, B. H. and Orr, H. T. Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. J Immunol 134: 2727–2733, 1985
Lassam, N. and Jay, G. Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcription initiation. J Immunol 143: 3792–3797, 1989
Lenardo, M., Rustgi, A. K., Schievella, R., and Bernards, R. Suppression of MHC class I gene expression by N-Myc through enhancer inactivation. EMBO J 8: 3351–3355, 1989
Li, L., Zhou, J., James, G., Heller-Harrison, R., Czech, M. P., and Olson, E. N. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71: 1181–1194, 1992
Littlewood, T. D., Amati, B., Land, H., and Evan, G. I. Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7: 1783–1792, 1992
Lu, Y., Touzjian, N., Stenzel, M., Dorfman, T., Sodroski, J. G., and Haseltine, W. A. Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1. J Virol 64: 5226–5229, 1990
Luscher, B., Mitchell, P. J., Williams, T., and Tjian, R. Regulation of transcriptional factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev 3: 1507–1517, 1989
Maschek, U., Pulm, W., Segal, S., and Hammerling, G. J. Major histocompatibility complex class I genes in murine fibrosarcoma IC9 are down regulated at the level of the chromatin structure. Mol Cell Biol 9: 3136–3142, 1989
Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., and Taniguchi, T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54: 903–913, 1988
Momburg, F., Ziegler, A., Harpprecht, J., Moller, P., Moldenhauer, G., and Hammerling, G. J. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J Immunol 142: 352–358, 1989
Moore, J. P., Hancock, D. C., Littlewood, T. D., and Evan, G. I. A sensitive and quantitative enzyme-linked immunosorbence assay for the c-Myc and N-Myc oncoproteins. Oncogene Res 2: 65–80, 1987
N'Guyen, C., Sodoyer, R., Trucy, J., Strachan, T., Jordan, B. R. The HLA-Aw24 gene: sequence, surroundings and comparison with HLA-A2 and-A3. Immunogenetics 21: 479–489, 1985
Opelz, G. Effect of HLA matching and transplant survival. Transplant Proc XIX: 641–646, 1987
Parham, P., Lawlor, D. A., Lomen, C. E., and Ennis, P. D. Diversity and diversification of HLA-A, B, C alleles. J Immunol 142: 3937–3950, 1989
Perkins, N. D., Schmid, R. M., Duckett, C. S., Leung, K., Rice, N. R., and Nabel, G. J. Distinct combinations of NFκB subunits determine the specificity of transcriptional activation. Proc Nat Acad Sci USA 89: 1529–1533, 1992
Pognonec, P., and Roeder, R. G. Recombinant 43-kDa USF binds to DNA and activates transcription in a manner indistiguishable from that of natural 43/44-kDa USF. Mol Cell Biol 11: 5125–5136, 1991
Roy, A. L., Meisterernst, M., Pognonec, P., and Roeder, R. G. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354: 245–248, 1991
Severinsson, L. and Peterson, P. A. Abrogation of cell surface expression of human class I transplantation antigens by an adenovirus protein in Xenopus laevis oocytes. J Cell Biol 101: 540–547, 1985
Sugita, K., Miyazaki, J.-I., Appella, E., and Ozato, K. Interferons increase transcription of a major histocompatibility class I gene via a 5′ interferon consensus sequence. Mol Cell Biol 7: 2625–2630, 1987
Tanaka, K., Isselbacher, K. J., Khoury, G., and Jay, G. Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science 228: 26–30, 1985
Thorogood, J., Persijn, G. G., Schreuder, G. M. T., D'Amaro, J., Zantvoort, F. A., van Houwelingen, J. C., and van Rood, J. J. The effect of HLA matching on kidney graft survival in separate posttransplantation intervals. Transplantation 50: 146–150, 1990
Vaessen, R. T. M. J., Houweling, A., and van der Eb, A. J. Post-transcriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. Science 235: 1486–1488, 1987
Versteeg, R., Kruse-Wolters, K. M., Plomp, A. C., van Leeuwen, A., Stam, N. J., Ploegh, H. L., Ruiter, D. J., and Schrier, P. I. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J Exp Med 170: 621–635, 1989
Versteeg, R., Noordermeer, I. A., Kruse-Wolters, M., Ruiter, D. J., and Schrier, P. I. c-myc down-regulates class I HLA expression in human melanomas. EMBO J 7: 1023–1029, 1988
Wallich, R., Bulbuc, N., Hämmerling, G. J., Katzav, S., Segal, S., and Feldman, M. Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 315: 301–305, 1985
Watts, S., Vogel, J. M., Harriman, W. D., Itoh, T., Stauss, H. J., and Goodenow, R. S. DNA sequence analysis of the C3H H-2K k and H-2D k loci. J Immunol 139: 3878–3885, 1987
Weiss, E. H., Kuon, W., Dorner, C., Lang, M., Reithmuller, G. Organization, sequence, and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations. Immunobiology 170: 367–380, 1985
Wilson, L. D., Flyer, D. C., and Faller, D. V. Murine retroviruses control class I major histocompatibility antigen gene expression via a trans effect at the transcriptional level. Mol Cell Biol 7: 2406–2415, 1987
Xiao, J. H., Davidson, I., Ferrandon, D., Rosales, R., Vigneron, M., Macchi, M., Ruffenach, F., and Chambon, P. One cell-specific and three ubiquitous nuclear proteins bind in vitro to overlapping motifs in the domain B1 of the SV40 enhancer. EMBO J 6: 3005–3013, 1987
Zinkernagel, R. M., and Doherty, P. C. MHC restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function and responsiveness. Adv Immunol 26: 51–142, 1979
Author information
Authors and Affiliations
Additional information
Correspondence to: J. Girdlestone.
Rights and permissions
About this article
Cite this article
Girdlestone, J. An HLA-B regulatory element binds a factor immunologically related to the upstream stimulation factor. Immunogenetics 38, 430–436 (1993). https://doi.org/10.1007/BF00184523
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00184523